HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

TNF-alpha coupled to membrane of apoptotic cells favors the cross-priming to melanoma antigens.

Abstract
The cross-presentation of Ags derived from apoptotic cell processing contributes to peripheral tolerance. Environmental signals possibly modify this default outcome, favoring cross-priming. In this study, we anchored via a biotin-avidin-biotin bridge soluble TNF-alpha to the membrane of apoptotic melanoma cells and studied in vivo and in vitro the interaction with Ag-presenting phagocytes. TNF-alpha-coated apoptotic melanoma cells injected s.c. had a faster and more efficient access to draining lymph nodes, with cross-priming of melanoma-specific CTLs and delayed outgrowth of melanomas in all treated animals. Twenty percent of the animals, in the absence of further adjuvant, did not develop the tumor. Immature dendritic cells challenged with TNF-alpha-coated apoptotic melanoma cells secreted proinflammatory cytokines in an autocrine/paracrine fashion, efficiently matured, as assessed functionally and by flow cytometry and cross-presented with enhanced efficiency melanoma Ags to MHC class I- and II-restricted T cells. The results indicate that TNF-alpha targeted to apoptotic membranes, at concentrations that can be safely reached in growing tumors without undue systemic toxicity, influences the outcome of the disposal of dying cells and enhances tumor immunogenicity.
AuthorsValérie S Zimmermann, Attilio Bondanza, Antonella Monno, Patrizia Rovere-Querini, Angelo Corti, Angelo A Manfredi
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 172 Issue 4 Pg. 2643-50 (Feb 15 2004) ISSN: 0022-1767 [Print] United States
PMID14764739 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adjuvants, Immunologic
  • Antigens, Neoplasm
  • Cancer Vaccines
  • Tumor Necrosis Factor-alpha
Topics
  • Adjuvants, Immunologic (administration & dosage, metabolism, physiology)
  • Animals
  • Antigen Presentation (immunology)
  • Antigens, Neoplasm (administration & dosage, immunology, metabolism)
  • Apoptosis (immunology)
  • Cancer Vaccines (administration & dosage, immunology, metabolism)
  • Cell Line
  • Cell Line, Tumor
  • Cell Membrane (immunology, metabolism)
  • Cell Movement (immunology)
  • Dendritic Cells (immunology, metabolism)
  • Lymph Nodes (immunology, pathology)
  • Melanoma, Experimental (immunology, pathology, prevention & control)
  • Mice
  • Mice, Inbred C57BL
  • Tumor Necrosis Factor-alpha (administration & dosage, metabolism, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: